Cargando…

Treatment Burden of Weekly Somatrogon vs Daily Somatropin in Children With Growth Hormone Deficiency: A Randomized Study

CONTEXT: Somatrogon is a long-acting recombinant human growth hormone treatment developed as a once-weekly treatment for pediatric patients with growth hormone deficiency (GHD). OBJECTIVE: Evaluate patient and caregiver perceptions of the treatment burden associated with the once-weekly somatrogon i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maniatis, Aristides K, Carakushansky, Mauri, Galcheva, Sonya, Prakasam, Gnanagurudasan, Fox, Larry A, Dankovcikova, Adriana, Loftus, Jane, Palladino, Andrew A, de los Angeles Resa, Maria, Turich Taylor, Carrie, Dattani, Mehul T, Lebl, Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Clinical Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9463876/ https://www.ncbi.nlm.nih.gov/pubmed/36101713 http://dx.doi.org/10.1210/jendso/bvac117

Ejemplares similares

Efficacy and Safety of Weekly Somatrogon vs Daily Somatropin in Children With Growth Hormone Deficiency: A Phase 3 Study
por: Deal, Cheri L, et al.
Publicado: (2022)

PMON329 Survey of physician experience with once weekly somatrogon vs once daily somatropin regimen for the treatment of pediatric patients with growth hormone deficiency: results from a cross sectional, observational study
por: Gomez, Roy, et al.
Publicado: (2022)

Switching to Weekly Lonapegsomatropin from Daily Somatropin in Children with Growth Hormone Deficiency: The fliGHt Trial
por: Maniatis, Aristides K., et al.
Publicado: (2022)

Efficacy and Safety of Once-Weekly Somatrogon Compared with Once-Daily Somatropin (Genotropin®) in Japanese Children with Pediatric Growth Hormone Deficiency: Results from a Randomized Phase 3 Study
por: Horikawa, Reiko, et al.
Publicado: (2022)

Somatrogon for growth hormone deficiency
Publicado: (2022)

THU170 Clinical And Immunological Response To Somatrogon In Two Siblings With A Homozygous Whole Gene Deletion Of The Growth Hormone 1 Gene
por: Gupta, Rahul, et al.
Publicado: (2023)

OR21-04 Long-term Efficacy And Safety Of Once-weekly Somatrogon In Pediatric Subjects With Growth Hormone Deficiency: Results From Up To 8 Years Of Somatrogon Treatment
por: Zadik, Zvi, et al.
Publicado: (2023)

Somatropin therapy in italian adults with growth hormone deficiency
por: Pricci, Flavia, et al.
Publicado: (2022)

Managing idiopathic short stature: role of somatropin (rDNA origin) for injection
por: Frindik, J Paul, et al.
Publicado: (2010)

Optimized Signal Peptide for Secretory Expression of Human Recombinant Somatropin in E. coli
por: Ahmadi, Zeynab, et al.
Publicado: (2023)

Effect of Twine-arginine Translocation-signaling Fusion System and Chaperones Co-expression on Secretory Expression of Somatropin
por: Bagherinejad, Mohammad Reza, et al.
Publicado: (2018)

Evaluation of human growth hormone (somatropin) in socket healing: a split-mouth randomized controlled trial
por: Sleman, Nadim, et al.
Publicado: (2023)

Osteometabolic profile and bone mass in the transition phase: ethnic differences in Brazilians treated with somatropin during childhood
por: Kuba, Valesca M., et al.
Publicado: (2022)

Physician experience with once-weekly somatrogon versus once-daily rhGH regimen in pediatric patients with growth hormone deficiency: a cross-sectional survey of physicians from the global phase 3 study
por: Gomez, Roy, et al.
Publicado: (2023)

Adding Ozone to Dextrose and Somatropin for Intra-articular Knee Prolotherapy: A Randomized Single-Blinded Controlled Trial
por: Imani, Farnad, et al.
Publicado: (2020)

OR10-06 Somatrogon Growth Hormone in the Treatment of Pediatric Growth Hormone Deficiency: Results of the Pivotal Pediatric Phase 3 Clinical Trial
por: Deal, Cheri L, et al.
Publicado: (2020)

Comparison of Quality of Life Responses From Caregiver and Children Aged ≥7 Years Using the Quality of Life in Short Stature Youth (QoLISSY) Questionnaire, Following 12 Months of Growth Hormone Treatment With Either a Weekly Somatrogon or a Daily Genotropin Injection Schedule
por: Loftus, Jane, et al.
Publicado: (2021)

Pattern of Use of Biosimilar and Originator Somatropin in Italy: A Population-Based Multiple Databases Study During the Years 2009–2014
por: Marcianò, Ilaria, et al.
Publicado: (2018)

SUN-LB15 A Case of Familial Male-Limited Precocious Puberty With a Novel Mutation
por: Owens, Lindsey L, et al.
Publicado: (2020)

A Case of Familial Male-limited Precocious Puberty with a Novel Mutation
por: Gurnurkar, Shilpa, et al.
Publicado: (2021)

THU153 Deep Vein Thrombosis As The Presenting Symptom In An Adolescent With New-Onset Type 2 Diabetes
por: Cooper, Felicia Ilyssa, et al.
Publicado: (2023)

Malignancy risk in adults with growth hormone deficiency undergoing long-term treatment with biosimilar somatropin (Omnitrope(®)): data from the PATRO Adults study
por: Beck-Peccoz, Paolo, et al.
Publicado: (2020)

Safety and effectiveness of Omnitrope(®) (somatropin) in PATRO Children: a multi-center, post-marketing surveillance study comparison of US and international cohort data
por: Backeljauw, Philippe, et al.
Publicado: (2022)

Severe Hypercalcemia in an Adolescent with New-Onset Diabetes Mellitus and Diabetic Ketoacidosis
por: Gurnurkar, Shilpa, et al.
Publicado: (2020)

LBODP018 Hypercalcemia In A Child On Ketogenic Diet For Intractable Epilepsy
por: Gurnurkar, Shilpa, et al.
Publicado: (2022)

Thyrotoxicosis and Impending Thyroid Storm: A Rare Paraneoplastic Syndrome in an Infant With Hepatoblastoma
por: Vyas, Neha, et al.
Publicado: (2023)

The Genetic and Molecular Mechanisms of Congenital Hyperinsulinism
por: Galcheva, Sonya, et al.
Publicado: (2019)

Long-term safety and efficacy of Omnitrope®, a somatropin biosimilar, in children requiring growth hormone treatment: Italian interim analysis of the PATRO Children study
por: Iughetti, Lorenzo, et al.
Publicado: (2016)

Prevalence of Vitamin D Deficiency in Children with Type 1 Diabetes Mellitus
por: Carakushansky, Mauri, et al.
Publicado: (2020)

Comparing Disease Severity: Diabetic Ketoacidosis in Local and Tourist Children With New-Onset Diabetes Mellitus
por: Hinds, Autumn, et al.
Publicado: (2021)

Two Unusual Cases of Pituitary Tumors Presenting with Pediatric Acromegaly
por: Gurnurkar, Shilpa, et al.
Publicado: (2022)

PMON336 Pfizer Registry of Outcomes in Growth hormone RESearch (PROGRES): A multi-country, non-interventional, prospective, cohort study of patients receiving human growth hormone treatments under routine clinical care
por: Geffner, Mitchell E, et al.
Publicado: (2022)

Ion Transporters, Channelopathies, and Glucose Disorders
por: Demirbilek, Huseyin, et al.
Publicado: (2019)

OR10-04 Interpretation of Insulin-like Growth Factor-1 (IGF-1) Levels Following Administration of Somatrogon (a Long-acting Human Growth Hormone - hGH-CTP)
por: Fisher, Dennis M, et al.
Publicado: (2020)

No increased risk of glucose metabolism disorders in adults with growth hormone deficiency undergoing long-term treatment with biosimilar somatropin (Omnitrope®): data from an observational, longitudinal study
por: Beck-Peccoz, Paolo, et al.
Publicado: (2019)

Initial Effect of Recombinant Human Growth Hormone Treatment in a Patient with Löwe Syndrome
por: Iotova, Violeta, et al.
Publicado: (2023)

Health Care Transition From Pediatric- to Adult-Focused Care in X-linked Hypophosphatemia: Expert Consensus
por: Dahir, Kathryn, et al.
Publicado: (2021)

The Future of Genomic Endocrinology
por: Dattani, Mehul T., et al.
Publicado: (2011)

Feasibility of Implementing a Pediatric Diabetes Clinic via Telehealth
por: Pierce, Jessica S., et al.
Publicado: (2021)

Erratum: Feasibility of Implementing a Pediatric Diabetes Clinic via Telehealth. Diabetes Spectrum 2021;34:190–197 (https://doi.org/10.2337/ds20-0060)
por: Pierce, Jessica S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kfbvlh432s51fr0vkqdtlparko